Multiple reports detail AI's growing role in biotech. NIH researchers unveiled GeneAgent, an AI agent reducing errors in gene-set analysis via database verification. Stanford scientists developed a virtual lab platform using AI agents to enhance scientific discovery, exemplified by accelerating SARS-CoV-2 vaccine design. Sanofi’s CEO revealed use of AI for objective drug development decisions, highlighting its dispassionate guidance. Trinity Biotech introduced CGM+, an AI-native wearable biosensor offering multi-parameter real-time health monitoring, poised to advance precision medicine. These developments signal an accelerating integration of AI and computational tools to transform R&D efficiency and patient care.